RANK Ligand Blocking Activity [MoA] - N0000187054
Pharmacologic Class Information
Pharmacologic Code | N0000187054 |
Pharmacologic Name | RANK Ligand Blocking Activity |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with RANK Ligand Blocking Activity
The table contains 2 products whose active ingredient are classified under the same pharmacologic class RANK Ligand Blocking Activity [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
55513-710 | Prolia | Non-Proprietary Name: Denosumab | Injection | Subcutaneous | Amgen Inc | ACTIVE | |
55513-730 | Xgeva | Non-Proprietary Name: Denosumab | Injection | Subcutaneous | Amgen Inc | ACTIVE |